A 21-Year-Old Male diagnosed with Bernard-Soulier Syndrome-Case Report

Bernard-Soulier Syndrome (BSS) is a rare autosomal recessive disorder characterized by the presence of large platelets and faulty platelet aggregation. Through this case report, we emphasize the various obstacles a male patient could face when diagnosed with BSS. Limited awareness and resources are among the most formidable challenges. Laboratory tests were carried out for the patient. They revealed severe thrombocytopenia (platelet count 8000/μL) and anemia (hemoglobin 9.7 g/dL). The clotting profile showed that prothrombin time and activated partial thromboplastin time were normal. It is crucial to recognize and manage this disease early, as inappropriate treatment will jeopardize the health of a patient who is suffering from recurrent mucocutaneous bleeding episodes. Financial barriers appear to be the most troublesome hindrances in conducting diagnostic tests and impeding the diagnosis. To reduce the rates of BSS and its effective management, heightened awareness among healthcare providers and the general population-particularly in communities with elevated rates of consanguinity is imperative.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-05-26
DOI
https://doi.org/10.5281/zenodo.15523002
Primary Topic
Platelet Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A 21-Year-Old Male diagnosed with Bernard-Soulier Syndrome-Case Report

Zenodo (CERN European Organization for Nuclear Research)
Platelet Disorders and Treatments
article

A 21-Year-Old Male diagnosed with Bernard-Soulier Syndrome-Case Report

article en

Abstract

Bernard-Soulier Syndrome (BSS) is a rare autosomal recessive disorder characterized by the presence of large platelets and faulty platelet aggregation. Through this case report, we emphasize the various obstacles a male patient could face when diagnosed with BSS. Limited awareness and resources are among the most formidable challenges. Laboratory tests were carried out for the patient. They revealed severe thrombocytopenia (platelet count 8000/μL) and anemia (hemoglobin 9.7 g/dL). The clotting profile showed that prothrombin time and activated partial thromboplastin time were normal. It is crucial to recognize and manage this disease early, as inappropriate treatment will jeopardize the health of a patient who is suffering from recurrent mucocutaneous bleeding episodes. Financial barriers appear to be the most troublesome hindrances in conducting diagnostic tests and impeding the diagnosis. To reduce the rates of BSS and its effective management, heightened awareness among healthcare providers and the general population-particularly in communities with elevated rates of consanguinity is imperative.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 38%
Platelet Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.